Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy
Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy
Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy
Submitted by
admin
on November 20, 2015 - 11:03am
Source:
Fierce Biotech
News Tags:
Pfizer
Cellectis
CAR-T
immuno-oncology
Headline:
Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy
Do Not Allow Advertisers to Use My Personal information
